Zobrazeno 1 - 2
of 2
pro vyhledávání: '"John Rømer Nielsen"'
Autor:
Mark M Souweidane, Kim Kramer, Neeta Pandit-Tasker, Sofia Haque, Pat Zanzonico, Jorge Carrasquillo, Serge K Lyashchenko, Sunitha B Thakur, Yasmin Khakoo, Ira J Dunkel, Maria Donzelli, Jason S Lewis, Nai-Kong V Cheung, Steve M Larson, Anne S Reiner, Katherine S Panageas, Nicole Manino, John Rømer Nielsen
Publikováno v:
Neuro-Oncology. 24:i30-i31
BACKGROUND: Median survival from DIPG is less than one year. In a phase 1 dose escalation study (clinicaltrials.gov NCT01502917) 124I-omburtamab targeting B7-H3 was administered intratumorally using CED. METHODS: CED was performed between 4-14 weeks
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2c4bbe49d9fcae15366160c73d26182
https://doi.org/10.1093/neuonc/noac079.110
https://doi.org/10.1093/neuonc/noac079.110
Publikováno v:
Journal for ImmunoTherapy of Cancer. 9:A429-A429
BackgroundLeptomeningeal metastasis (LM) from solid tumors may be diagnosed in approximately 10% of patients with metastatic cancer and can occur with virtually all malignant tumors. Median overall survival (OS) is poor and limited to a few months wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b92af36ee23f733e31581b7e6abda68f
https://doi.org/10.1136/jitc-2021-sitc2021.397
https://doi.org/10.1136/jitc-2021-sitc2021.397